Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Cencora
COR Rank #171 Health Care
$368.19 -0.87%

Key Statistics

Market Cap
$71.62B
Volume (24h)
$461.6M
P/E Ratio
44.3
EPS
$8.31
1 Day
-0.87%
7 Day
+1.05%
YTD
+9.85%
Sector
Health Care
S&P 500 Rank
#171
52W Low: $302.47 52W High: $448.64

About Cencora

Cencora is a pharmaceutical company that develops, manufactures, and commercializes a portfolio of generic and specialty pharmaceutical products, including respiratory and dermatology treatments. The company's product offerings include a range of generic and branded medications, as well as a pipeline of in-development products. As a leading player in the pharmaceutical industry, Cencora plays a critical role in providing affordable and accessible healthcare solutions to patients worldwide.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,003.57 -0.41% JNJ — Johnson & Johnson $245.30 -0.59% ABBV — AbbVie $236.19 +1.00% MRK — Merck & Co. $120.28 +0.38% UNH — UnitedHealth Group $291.96 +0.95% AMGN — Amgen $379.27 +0.60% ABT — Abbott Laboratories $113.10 -0.45% TMO — Thermo Fisher Scientific $512.69 +0.90% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.